Concepedia

Hitesh Bhayani

HB

Statistics

Publications

3

Citations

41

H-Index

3

Active since

2018

Affiliations

Cadila Healthcare (India)(Current)

Hitesh Bhayani is an author at Cadila Healthcare (India) specializing in drug discovery, pharmacotherapy, and medicine.

Top concepts

Publications per year

2018–2021

3

Publications

3

Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes

Sameer Agarwal, Santosh Sasane, Jeevan Kumar et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 14 citations · Full text

, , +7

Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19)

Jigar Desai, Bhaumin Patel, Brijesh Darji et al. · Bioorganic & Medicinal Chemistry Letters · 2021 · 14 citations

, , +8

ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer

Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani et al. · Pharmacology Research & Perspectives · 2020 · 13 citations · Full text

1–3 of 3